Brind.
  1. Ocugen addressed unmet medical needs for Stargardt patients through recent announcements regarding their research in Europe.

Ocugen is updating its Retina Scientific Advisory Board, while Peter K Kaiser holds chairs at Cleveland Clinic and Ophthalmic Consultants of Boston.

1 report, 1 independent Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ocugen is updating its Retina Scientific Advisory Board, while Peter K Kaiser holds chairs at Cleveland Clinic and Ophthalmic Consultants of Boston.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireOcugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: O